Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
JangoBio
AddedFeb 16, 2024
UpdatedJun 18, 2026
JangoBio

JangoBio

Seed

JangoBio: A biotech firm innovating regenerative therapies for age-related hormone imbalances.

HQ
Fitchburg, WI, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

JangoBio, founded with a mission to combat aging and age-related diseases, focuses on developing regenerative therapies to restore hormone balance. The company's vision is to enhance health and wellbeing through innovative biotechnology solutions. JangoBio's primary products include regenerative stem cell therapies designed to address hormone imbalances that occur with aging, such as those experienced during menopause and andropause. Their market focus is on individuals seeking advanced treatments for age-related hormonal decline.

Notable figures associated with JangoBio include leading scientists and biotech experts who drive the company's research and development efforts. The company has attracted significant interest from investors in the biotech sector, recognizing its potential to revolutionize age-related healthcare. Key achievements include the development of pioneering therapies that have shown promise in preclinical studies. JangoBio's impact lies in its potential to significantly improve quality of life for aging populations by addressing the root causes of hormonal imbalances.

JangoBio - Similar Companies

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Juvenescence logo

Juvenescence

juvlabs.com

Endogena Therapeutics logo

Endogena Therapeutics

Rejuvenate Bio logo

Rejuvenate Bio

rejuvenatebio.com

Longeveron logo

Longeveron

longeveron.com

AgeX Therapeutics logo

AgeX Therapeutics

Rejuveron Life Sciences logo

Rejuveron Life Sciences

rejuveron.com

42Bio logo

42Bio

42bio.com

Cellebration Life Sciences logo

Cellebration Life Sciences

Retro Biosciences logo

Retro Biosciences

retro.bio

Angiocrine Bioscience logo

Angiocrine Bioscience

MenoGeniX logo

MenoGeniX

menogenix.com

GentiBio logo

GentiBio

gentibio.com

BioViva logo

BioViva

JangoBio - Quick Facts

Who are JangoBio's competitors?

Companies similar to JangoBio include Juventas Therapeutics, Regenerative Bio, Juvenescence and Endogena Therapeutics.

When was JangoBio founded?

JangoBio was founded in 2015.

Where is JangoBio's headquarters located?

JangoBio's headquarters is located in Fitchburg, WI, US.

When was JangoBio's last funding round?

JangoBio's most recent funding round was for $112.5k (USD) in January 2018.

How much has JangoBio raised to-date?

As of Jan 1, 2018, JangoBio has raised a total of $2.5M (USD).

How many employees does JangoBio have?

JangoBio has 15 employees as of Feb 5, 2024.

JangoBio - Classification

Industry
  • Therapeutics
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Stem Cell Therapies
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified